ITGA4 has previously been implicated in myeloma cell homing, survival, and acquisition of cell-adhesion mediated drug resistance (Nishinarita et al. 1998, Hosen 2020, Nair-Gupta et al. 2020, Hathi et al. 2022). Here, ITGA4 is linked to plasma cell myeloma.